Both in Biotechnology
Cullinan Therapeutics vs Attovia Therapeutics
Over the past year CGEM returned −37.2% and ATTO returned −39.8%; their daily moves had a correlation of 0.45.
CGEM −37.2% ATTO −39.8%Growth of $1, one year, split-adjusted
| Metric | CGEM | ATTO |
|---|---|---|
| Price | $12.93 | $13.73 |
| Market cap | $832.1M | $626.8M |
| Today | −7.64% | −7.10% |
| 1 month | −39.5% | −39.6% |
| 6 months | −14.1% | — |
| Year to date | +24.9% | — |
| 1 year | +49.8% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $334.5M | — |
| Dividend yield | — | — |
| Volatility (60d) | 74.2% | — |
| Short % of float | 14.3% | 6.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).